Bio-medical beauty group UltraV (CEO Hanjin Kwon) announced on the 6th that it has successfully ended a global academic seminar to commemorate the launch of "UltraCol," which has recently attracted worldwide attention for its unrivaled technology.

​Kuwait is a Middle Eastern country with a population of about 4.32 million and is an emerging market in the medical and beauty industries. In particular, because of its great influence on neighboring countries, it is evaluated as a bridgehead for the beauty and medical field to enter the Middle East.

​"UltraCol," which has been officially approved by countries around the world, including Asia, the Middle East, Europe, and the Americas, beyond Korea and is increasing its global market share, obtained approval from the Ministry of Food and Drug Safety of Thailand in June. CEO Hanjin Kwon, the head of K-beauty evangelist, is working on overseas seminars and lectures around the world every week despite his busy schedule to share excellent domestic technology.

​‘UltraCol’ is a product manufactured with technology that processes into spherical PDO (POLIDIOXANONE) fine particles (microspheres), and has opened a new chapter in the anti-aging market by obtaining Korean Food and Drug Administration (KFDA) and European CE certification

It is a collagen-producing stimulant that promotes self-collagen production by foreign body reaction and later decomposes to lower the risk of side effects, and it has attracted attention for not only improving skin elasticity and whitening effects, but also expressing lifting effects.

​As it won the IR52 Jang Young-sil Award for the first time in the polymer filler, won the Korea's Best Patent Award for its unrivaled technology, and is creating a new wind in the global anti-aging market, questions poured out at the lecture as if reflecting the high interest of participants, and local medical staff and officials continued to respond with high response as they had time to feel the features of "UltraCol."

CEO Hanjin Kwon, the K-beauty evangelist, said, "We are honored and pleased to launch the ‘Ultracol ‘so that Kuwait customers can experience ‘Ultracol ‘in person, thanks to the popularity of ‘Ultracol, ‘which is receiving a lot of attention from around the world. We will continue to make various efforts to experience ‘Ultracol’ in person around the world."

​Meanwhile, UltraV is directly researching, developing, producing, and selling to lead the global popularization of the cosmetic medical device market. Following its flagship product, UltraCol, all three types of HA fillers, Ultra V hyal fillers, have received product approval from the Thai Ministry of Food and Drug Safety (TFDA), which is expected to further enhance its competitiveness in the global cosmetic medical market.

​

​

​